Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2024 Rank: 9351
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 360 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9351 | 9321 |
| Total Cites | 47909 | 55896 |
| H-index | 102 | 110 |
| Hm-index | 27 | 29 |
| Number of Single Authored Papers | 42 | 42 |
| Total Cites to Single Authored Papers | 509 | 531 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 4143 | 4567 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 6187 | 6882 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 33039 | 36437 |
| Ratio of Total Citations to Distinct Citing Papers | 1.45 | 1.53 |
| Self-Citation Percentage |
14.29%
|
|
Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2023 Rank: 9624
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 375 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9624 | 9683 |
| Total Cites | 42964 | 50261 |
| H-index | 99 | 105 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 41 | 41 |
| Total Cites to Single Authored Papers | 502 | 524 |
| Number of Single+First Authored Papers | 72 | 72 |
| Total Cites to Single+First Authored Papers | 3853 | 4247 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 5685 | 6331 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 29943 | 33090 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.52 |
| Self-Citation Percentage |
14.52%
|
|
Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2022 Rank: 9810
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 385 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9810 | 10037 |
| Total Cites | 38317 | 44959 |
| H-index | 95 | 101 |
| Hm-index | 24 | 26 |
| Number of Single Authored Papers | 39 | 39 |
| Total Cites to Single Authored Papers | 492 | 514 |
| Number of Single+First Authored Papers | 70 | 70 |
| Total Cites to Single+First Authored Papers | 3503 | 3864 |
| Number of Single+First+Last Authored Papers | 132 | 132 |
| Total Cites to Single+First+Last Authored Papers | 5123 | 5712 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 26972 | 29893 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.50 |
| Self-Citation Percentage |
14.77%
|
|
Stone, Richard M.
Dana-Farber Cancer Institute,
United States
2021 Rank: 9931
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 386 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 9931 | 10173 |
| Total Cites | 36106 | 42406 |
| H-index | 92 | 98 |
| Hm-index | 24 | 25 |
| Number of Single Authored Papers | 37 | 37 |
| Total Cites to Single Authored Papers | 477 | 498 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 3332 | 3674 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 4834 | 5393 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 25589 | 28389 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.49 |
| Self-Citation Percentage |
14.86%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.